Donor Natural Killer Cells, Cyclophosphamide, and Etoposide in Treating Children and Young Adults With Relapsed or Refractory Solid Tumors
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Pfizer
MacroGenics
Yale University
Bolt Biotherapeutics, Inc.
Tempus AI
HiFiBiO Therapeutics
Actym Therapeutics, Inc.
Day One Biopharmaceuticals, Inc.
Pfizer
Pfizer
NuCana plc
University of Virginia
NRG Oncology
Mayo Clinic
Turnstone Biologics, Corp.
Incyte Corporation
Seagen Inc.
Incyte Corporation
Seagen Inc.
University of California, San Diego
Sotio Biotech Inc.
ImaginAb, Inc.
Pfizer
Molecular Templates, Inc.
Inhibrx Biosciences, Inc
Novartis
Pfizer
ADC Therapeutics S.A.
Pfizer
Vanderbilt University Medical Center
University of Florida
Novartis
Fate Therapeutics
4D pharma plc
Nektar Therapeutics
Advaxis, Inc.
Rubius Therapeutics
Duke University
Genocea Biosciences, Inc.
TC Biopharm
MacroGenics
Incyte Corporation
Cambridge University Hospitals NHS Foundation Trust
Tocagen Inc.
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
Yale University
National Institutes of Health Clinical Center (CC)
Hoffmann-La Roche